Botulinum toxin type A in the management of resistant Raynaud's phenomenon secondary to autoimmune systemic connective tissue diseases
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI